Search | OpenScholar

Search results

1498 results found

Congwu Chi

Person: Assistant Professor

I am an assistant professor. I got my PhD degree at Fudan University in China and finished my postdoc training in Dr. Min Han’s group in University of Colorado at Boulder. Both my education and trainings in China as well as in USA have provided me with a deep understanding of Developmental Biology...

Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. 2022 Dec;175(12):1666-1674. doi: 10.7326/M22-1438. Epub 2022 Nov 8. PMID: 36343348

Publication: Journal Article

Camilleri, M, T Subramanian, F Pagan, S Isaacson, R Gil, RA Hauser, M Feldman, and M Goldstein. 2022. “Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. 2022 Dec;175(12):1666-1674. Doi: 10.7326/M22-1438. Epub 2022 Nov 8. PMID: 36343348”. Ann Intern Med.

The Clinical Development of Levodopa Inhalation Powder. 2023 Mar-Apr 01;46(2):66-78. doi: 10.1097/WNF.0000000000000540. Epub 2023 Jan 29. PMID: 36715241

Publication: Journal Article

Hauser, RA, PA LeWitt, CH Waters, DG Grosset, and B Blank. 2023. “The Clinical Development of Levodopa Inhalation Powder. 2023 Mar-Apr 01;46(2):66-78. Doi: 10.1097/WNF.0000000000000540. Epub 2023 Jan 29. PMID: 36715241”. Clin Neuropharmacol.

Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy. American journal of human genetics, 104(6), 1210–1222.

Publication: Journal Article

“Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy. American Journal of Human Genetics, 104(6), 1210–1222.”. 2019. American Journal of Human Genetics.

Medical Management and Prevention of Motor Complications in Parkinson's Disease. Neurotherapeutics 2020;17:1339-1365.

Publication: Journal Article

Aradi, SD, and RA Hauser. 2020. “Medical Management and Prevention of Motor Complications in Parkinson’s Disease. Neurotherapeutics 2020;17:1339-1365.”. Neurotherapeutics.

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism Relat Disord 2020;80:127-132.

Publication: Journal Article

Mills, KA, RB Schneider, M Saint-Hilaire, GW Ross, RA Hauser, AE Lang, MJ Halverson, et al. 2020. “Cognitive Impairment in Parkinson’s Disease: Associations Between Subjective and Objective Cognitive Decline in a Large Longitudinal Study. Parkinsonism Relat Disord 2020;80:127-132.”. Parkinsonism Relat Disord.

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.

Publication: Journal Article

Hauser, RA, and . 2020. “Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies. Front Neurol. 2020;11:576117.”. Front Neurol.

On demand therapy for Parkinson's disease patients: Opportunities and choices. Postgrad Med. 2021 Sep;133(7):721-727. doi: 10.1080/00325481.2021.1936087.

Publication: Journal Article

Hauser, RA, PA LeWitt, and CL Comella. 2021. “On Demand Therapy for Parkinson’s Disease Patients: Opportunities and Choices. Postgrad Med. 2021 Sep;133(7):721-727. Doi: 10.1080/00325481.2021.1936087.”. Postgrad Med.

A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson's Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. doi: 10.3390/s21165437. PMID: 34450879.

Publication: Journal Article

Rupprechter, S, G Morinan, Y Peng, T Foltynie, K Sibley, RS Weil, LA Leyland, et al. 2021. “A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. Doi: 10.3390/S21165437. PMID: 34450879.”. Sensors (Basel).

Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. doi: 10.3233/JPD-212672. PMID: 34486986

Publication: Journal Article

Hauser, RA, N Hattori, H Fernandez, SH Isaacson, H Mochizuki, O Rascol, F Stocchi, et al. 2021. “Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, As Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. J Parkinsons Dis. 2021;11(4):1663-1675. Doi: 10.3233/JPD-212672. PMID: 34486986”. J Parkinsons Dis.